12:00 AM
Sep 19, 2013
 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information
Alzheimer's disease (AD); neurology 3-Phosphoinositide-dependent protein kinase-1 (PDPK1) Mouse and cell culture studies suggest...

Read the full 205 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >